title: The bile response repressor BreR regulates expression of the Vibrio cholerae breAB efflux system operon.
abstract: Enteric pathogens have developed several resistance mechanisms to survive the antimicrobial action of bile. We investigated the transcriptional profile of Vibrio cholerae O1 El Tor strain C6706 under virulence gene-inducing conditions in the presence and absence of bile. Microarray analysis revealed that the expression of 119 genes was affected by bile. The mRNA levels of genes encoding proteins involved in transport were increased in the presence of bile, whereas the mRNA levels of genes encoding proteins involved in pathogenesis and chemotaxis were decreased. This study identified genes encoding transcriptional regulators from the TetR family (vexR and breR) and multidrug efflux pumps from the resistance-nodulation-cell division superfamily (vexB and vexD [herein renamed breB]) that were induced in response to bile. Further analysis regarding vexAB and breAB expression in the presence of various antimicrobial compounds established that vexAB was induced in the presence of bile, sodium dodecyl sulfate, or novobiocin and that the induction of breAB was specific to bile. BreR is a direct repressor of the breAB promoter and is able to regulate its own expression, as demonstrated by transcriptional and electrophoretic mobility shift assays (EMSA). The expression of breR and breAB is induced in the presence of the bile salts cholate, deoxycholate, and chenodeoxycholate, and EMSA showed that deoxycholate is able to abolish the formation of BreR-P(breR) complexes. We propose that deoxycholate is able to interact with BreR and induce a conformational change that interferes with the DNA binding ability of BreR, resulting in breAB and breR expression. These results provide new insight into a transcriptional regulator and a transport system that likely play essential roles in the ability of V. cholerae to resist the action of bile in the host.
authors.affiliation: Department of Microbiology and Immunology, HB7550, Dartmouth Medical School, Hanover, NH 03755, USA.
authors.forename: Francisca A
authors.initials: FA
authors.lastname: Cerda-Maira
authors.forename: Carol S
authors.initials: CS
authors.lastname: Ringelberg
authors.forename: Ronald K
authors.initials: RK
authors.lastname: Taylor
mesh_terms: D000890:Anti-Infective Agents / Q000494:pharmacology; D001426:Bacterial Proteins / Q000235:genetics* / Q000378:metabolism; D001647:Bile Acids and Salts / Q000494:pharmacology*; D002635:Chenodeoxycholic Acid / Q000494:pharmacology; D020355:Cholates / Q000494:pharmacology; D003840:Deoxycholic Acid / Q000494:pharmacology; D024202:Electrophoretic Mobility Shift Assay; D015964:Gene Expression Regulation, Bacterial / Q000187:drug effects*; D008957:Models, Genetic; D009675:Novobiocin / Q000494:pharmacology; D020411:Oligonucleotide Array Sequence Analysis; D009876:Operon / Q000235:genetics; D011401:Promoter Regions, Genetic / Q000235:genetics; D011485:Protein Binding / Q000187:drug effects; D012967:Sodium Dodecyl Sulfate / Q000494:pharmacology; D024363:Transcription Initiation Site; D014734:Vibrio cholerae / Q000235:genetics* / Q000378:metabolism
chemical_list: D000890:Anti-Infective Agents; D001426:Bacterial Proteins; D001647:Bile Acids and Salts; D020355:Cholates; D003840:Deoxycholic Acid; D002635:Chenodeoxycholic Acid; D009675:Novobiocin; D012967:Sodium Dodecyl Sulfate
references.citation: Gene. 1985;36(1-2):159-67
references.pmid: 3934044
references.citation: J Biol Chem. 2003 Dec 19;278(51):51307-15
references.pmid: 14534317
references.citation: J Bacteriol. 1995 Jul;177(14):4162-5
references.pmid: 7608095
references.citation: Antimicrob Agents Chemother. 1999 Nov;43(11):2624-8
references.pmid: 10543738
references.citation: FEMS Microbiol Rev. 2005 Sep;29(4):625-51
references.pmid: 16102595
references.citation: Antimicrob Agents Chemother. 2005 Mar;49(3):1067-75
references.pmid: 15728904
references.citation: Science. 1994 Apr 15;264(5157):418-20
references.pmid: 8153629
references.citation: Mol Microbiol. 2002 Nov;46(4):1135-47
references.pmid: 12421317
references.citation: J Bacteriol. 2003 Aug;185(16):4825-36
references.pmid: 12897002
references.citation: J Mol Biol. 1983 Sep 25;169(3):707-21
references.pmid: 6313933
references.citation: Arch Microbiol. 2006 Sep;186(3):171-81
references.pmid: 16804679
references.citation: J Biol Chem. 2006 Mar 17;281(11):7102-9
references.pmid: 16407274
references.citation: Antimicrob Agents Chemother. 2003 Oct;47(10):3067-72
references.pmid: 14506010
references.citation: Infect Immun. 1997 Mar;65(3):1131-4
references.pmid: 9038330
references.citation: J Bacteriol. 2005 Nov;187(21):7417-24
references.pmid: 16237025
references.citation: Infect Immun. 2003 Aug;71(8):4250-9
references.pmid: 12874300
references.citation: J Bacteriol. 1999 Jul;181(14):4250-6
references.pmid: 10400582
references.citation: Microbiol Mol Biol Rev. 2005 Jun;69(2):326-56
references.pmid: 15944459
references.citation: J Biol Chem. 1998 Jul 17;273(29):18665-73
references.pmid: 9660841
references.citation: Mol Microbiol. 2006 Jan;59(1):193-201
references.pmid: 16359328
references.citation: Antimicrob Agents Chemother. 1996 Sep;40(9):2021-8
references.pmid: 8878574
references.citation: Antimicrob Agents Chemother. 2002 Jul;46(7):2124-31
references.pmid: 12069964
references.citation: Mol Microbiol. 2001 Jul;41(2):393-407
references.pmid: 11489126
references.citation: J Bacteriol. 2001 Mar;183(6):2025-31
references.pmid: 11222601
references.citation: Mol Microbiol. 1996 Jan;19(1):101-12
references.pmid: 8821940
references.citation: J Bacteriol. 1999 Mar;181(5):1508-14
references.pmid: 10049382
references.citation: Mol Microbiol. 1999 Aug;33(3):651-8
references.pmid: 10417654
references.citation: Infect Immun. 2000 Mar;68(3):1491-7
references.pmid: 10678965
references.citation: Infect Immun. 2001 Jul;69(7):4681-5
references.pmid: 11402016
references.citation: J Biol Chem. 2001 Jan 12;276(2):1479-85
references.pmid: 11050092
references.citation: J Bacteriol. 2004 Oct;186(20):6809-14
references.pmid: 15466033
references.citation: Gene. 1996 Feb 22;169(1):47-52
references.pmid: 8635748
references.citation: Proc Natl Acad Sci U S A. 1988 Dec;85(23):8998-9002
references.pmid: 2461560
references.citation: Microbiol Mol Biol Rev. 2002 Dec;66(4):671-701, table of contents
references.pmid: 12456787
references.citation: Mol Microbiol. 1998 Jan;27(1):63-72
references.pmid: 9466256
references.citation: J Bacteriol. 1996 Oct;178(19):5803-5
references.pmid: 8824631
references.citation: Proc Natl Acad Sci U S A. 1990 Dec;87(24):9898-902
references.pmid: 2124707
references.citation: Science. 2005 Oct 28;310(5748):670-4
references.pmid: 16223984
references.citation: Drugs. 2004;64(2):159-204
references.pmid: 14717618
references.citation: Mol Microbiol. 1995 Apr;16(1):45-55
references.pmid: 7651136
references.citation: Microbiol Immunol. 1986;30(11):1075-83
references.pmid: 3543624
references.citation: Mol Microbiol. 2005 Jul;57(2):420-33
references.pmid: 15978075
references.citation: J Mol Biol. 2005 Jun 3;349(2):387-400
references.pmid: 15890203
references.citation: Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10220-4
references.pmid: 10944196
references.citation: FEMS Microbiol Lett. 1996 Jan 15;135(2-3):161-7
references.pmid: 8595853
references.citation: J Bacteriol. 2004 Sep;186(17):5640-8
references.pmid: 15317768
references.citation: Antimicrob Agents Chemother. 2000 Sep;44(9):2242-6
references.pmid: 10952562
references.citation: Microbes Infect. 2000 Jul;2(8):907-13
references.pmid: 10962274
references.citation: Microbiology (Reading). 2004 Apr;150(Pt 4):775-783
references.pmid: 15073288
references.citation: J Bacteriol. 1995 Jul;177(14):4121-30
references.pmid: 7608087
references.citation: Mol Microbiol. 2004 Jul;53(2):697-706
references.pmid: 15228545